Oric Pharmaceuticals (ORIC) Assets Average (2020 - 2026)

Oric Pharmaceuticals' Assets Average history runs 7 years deep, the most recent figure standing at $422.8 million for Q1 2026.

• Quarterly Assets Average rose 63.57% year-over-year to $422.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $422.8 million (up 63.57% YoY) and the FY2025 annual result came in at $341.5 million, up 29.82% from the prior year.
• Assets Average was $422.8 million for Q1 2026 at Oric Pharmaceuticals, up from $420.0 million in the prior quarter.
• Across five years, Assets Average topped out at $422.8 million in Q1 2026 and bottomed at $236.9 million in Q1 2023.
• A 5-year average of $301.1 million and a median of $286.9 million in 2022 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2022 — Assets Average fell 20.83% — and 2026, when it jumped 63.57%.
• Oric Pharmaceuticals' Assets Average stood at $242.6 million in 2022, then climbed by 8.48% to $263.2 million in 2023, then climbed by 9.47% to $288.1 million in 2024, then soared by 45.79% to $420.0 million in 2025, then grew by 0.66% to $422.8 million in 2026.
• Business Quant data shows ORIC's Assets Average at $422.8 million in Q1 2026, $420.0 million in Q4 2025, and $389.0 million in Q3 2025.